FDA advisers vote in favor of authorizing Novavax Covid vaccine

An FDA committee has voted to recommend Novavax’s Covid-19 vaccine for use for adults 18 and older in the U.S. This vaccine uses protein technology that is different from Pfizer and Moderna’s messenger RNA shots. CNBC’s senior health and science reporter Meg Tirrell reports.